Post-marketing Monitoring and Evaluation System in Japan
MENG Kangkang1, SUN Nan2, DONG Duo1*
1Center for Drug Reevaluation, NMPA/NMPA Key Laboratory for Research and Evaluation of Pharmacovigilance, Beijing 100022, China; 2Astellas Pharmaceutical (China) Co., Ltd., Beijing 100022, China
MENG Kangkang, SUN Nan, DONG Duo. Post-marketing Monitoring and Evaluation System in Japan[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 944-948.
[1] Zhang Q, Yan JZ, Yao W.Study on the legal system of drug reevaluation in USA, EU and Japan and its enlightenment to China[J].China Pharmacy(中国药房), 2019, 30(18): 2449-2454. [2] Xiang JQ, Ye H.Analysis on the relevant system of drug reevaluation after marketing abroad[J]. Chinese Pharmaceutical Affairs(中国药事), 2016, 30(4): 406-410. [3] Ministry of Health, Labour and Welfare. MHLW Organization Chart [EB/OL].(2018-01-30)[2020-11-06].https://www.mhlw.go.jp/english/org/detail/dl/organigram.pdf. [4] Pharmaceuticals and Medical Devices Agency. PMDA Organization [EB/OL].(2020-04-01)[2020-11-25].https://www.pmda.go.jp/english/about-pmda/outline/0003.html. [5] Pharmaceuticals and Medical Devices Agency. Implementation of drug provisions of MHLW ordinance No.116/2017 on Amendments of good post-marketing study practice [EB/OL].(2017-10-26) [2020-03-25]. https://www.pmda.go.jp/files/000220766.pdf. [6] Zhang ZY, Liu H, Yang Y.Study on new drug reexamination system in Japan[J]. Herald of Medicine(医药导报),2019, 38(1): 119-122. [7] Liu J, Li CL, Guo LH, et al.Research on system of post-marketing evaluation in Japan[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(3): 158-160. [8] Yamaguchi M, Inomata S, Harada S, et al.Establishment of the MID-NET medical information database network as a reliable and valuable database for drug safety assessments in Japan[J].Pharmacoepidemiology and Drug Safety, 2019, 28(7): 1395-1404. [9] Pharmaceuticals and Medical Devices Agency. Partial Amendment of Settling on Risk Management Plan (RMP) [EB/OL].(2017-12-05) [2020-05-13]. https://www.pmda.go.jp/files/000221116.pdf. [10] Hu XY, Liang YQ, Zeng LY.Comparative study of pharmacovigilance system between China and Japan[J]. Chinese Journal of Rational Drug Use(中国合理用药探索),2020, 17(3): 16-20.